Parenting Intervention for Mothers With Substance Use Disorder
Status
Conditions
Treatments
Details and patient eligibility
About
Children of mothers with substance use disorder (SUD) constitute a growing and highly vulnerable population. Evidence-based parenting interventions have the potential to both support parents' recovery and mental health by helping them cope with stress of parenthood and promote the optimal development of their children by supporting responsive parenting. The Supporting Our Families through Addiction and Recovery (SOFAR) pediatric medical home for families and children impacted by SUDs, with integrated behavioral health (IBH), provides an opportune setting for addressing the needs of mothers and children impacted by SUDs. While many families are thriving in the program, there is a strong unmet need for evidence-based parent-training interventions, particularly during the preschool period.
This study aims to evaluate the implementation of a brief, parent child interaction therapy (PCIT)-based intervention, entitled Threat, harm, risk, investigation, vulnerability and engagement (THRIVE), that will be offered in the SOFAR Clinic at Boston Medical Center. THRIVE is a safe, 6-session telehealth intervention that has been tested in pediatric and community-based settings. The evidence-based suggests that THRIVE is associated with significant improvements in child behaviors and parenting stress.
The investigators hypothesize that offering THRIVE through the SOFAR pediatric primary care program will be feasible and acceptable, improving access to and engagement in evidence-based parenting interventions among mothers with substance use disorder who receive parenting support through our integrated behavioral health model. In addition to studying the implementation of this evidence-based intervention, this study will allow the researchers to test data collection procedures (pre and post-interventions assessments) to inform a future clinical trial.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Mothers:
- English speaking
- ≥ 18 years of age
- Mother to an index child between 3 years, 0 months to 6 years, 11 months of age who receives primary care at Boston Medical Center
- Primary caregiver to the index child,
- Engaged in formal SUD recovery supports (e.g., medication for opioid use disorder, support groups specific to people in recovery and falls into one of these two enrollment groups: A) "high-risk" substance use disorder defined >=1 episode of relapse within the past two years OR B) "low-risk" defined as zero episodes of relapse within the past two years.
Children:
- Between 3 years, 0 months to 6 years, 11 months of age,
- Enrolled mother is primary caregiver.
THRIVE Therapist:
- Embedded social worker in the SOFAR program delivering the THRIVE intervention
Clinical Stakeholders:
- Patient Navigators, program manager, pediatricians, peer recovery coaches involved in the care of mother-child dyads in the SOFAR Program.
Exclusion criteria
Mothers:
- Has an index child who has complex medical problems (e.g., autism spectrum disorder) that significantly impact the child's ability to interact with the parent (determination by child's primary care pediatrician)
- Severe cognitive limitation or medical or psychiatric condition that limits their capacity to provide informed consent
- Concurrent participation in another parent training intervention
Children:
- Has any complex medical problems (as assessed by their pediatrician) that significantly impact the child's ability to interact with the mother.
Trial design
Primary purpose
Allocation
Interventional model
Masking
9 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Priyanka Srivastava, MS; Mei Elansary, MD MPhil
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal